Nicotine dependence

3 trials 1 recruiting MedDRA PT
3 Registered trials
1 Recruiting
3 Unique sponsors
2 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 2
N Neurology/Psychiatry (ATC N) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Phase IV: 1 Phase I (Other): 1 Other: 1

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase IV

1 trial
  • Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy Academic
    CYTISINICLINE; NICOTINE
    2023-509235-39-00 1 country 2025 n=292
    Recruiting

Phase I (Other)

1 trial
  • Niconovum AB Commercial
    IMP not specified
    2024-514676-40-00 1 country 2024 n=15
    Ended

Other

1 trial
  • LTS LOHMANN Therapie-Systeme AG Commercial
    IMP not specified
    2023-503548-14-00 1 country 2024 n=30
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
LTS LOHMANN Therapie-Systeme AG Commercial 1 Other 0
Niconovum AB Commercial 1 Phase I (Other) 0
Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy Academic 1 Phase IV 1
New trials by year
2024
2
2025
1
← All indication landscapes